Fulgent Genetics earnings were -$163.4M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest FLGT earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$8.7M, down 35.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, FLGT reported annual earnings of -$167.8M, with -217% growth. The next FLGT earnings date is Nov 1, 2024.
What were Fulgent Genetics's earnings last quarter?
On FLGT's earnings call on Invalid Date, Fulgent Genetics (NASDAQ: FLGT) reported Q2 2024 earnings per share (EPS) of -$0.29, up 23.68% year over year. Total FLGT earnings for the quarter were -$8.71 million. In the same quarter last year, Fulgent Genetics's earnings per share (EPS) was -$0.38.
The next FLGT earnings date is Invalid Date. Add FLGT to your watchlist to be reminded of Fulgent Genetics's next earnings date.
Is Fulgent Genetics profitable or losing money?
As of the last Fulgent Genetics earnings report, Fulgent Genetics is currently losing money. Fulgent Genetics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$163.43 million, a 235.71% increase year over year.
What was FLGT's earnings growth in the past year?
As of Fulgent Genetics's earnings date in Invalid Date, Fulgent Genetics's earnings has grown year over year. FLGT earnings in the past year totalled -$163.43 million.
What are Fulgent Genetics's earnings expectations?
The current EPS estimate for Fulgent Genetics's earnings report in Invalid Date is -$0.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.